Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating umbilical cord blood transplantation for high-risk hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Myelodoproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Umbilical Cord Blood Transplantation

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Graft Versus Host Disease, Leukemia | Phase 2 | Status: COMPLETED